Uganda launches 42-day countdown to Ebola-free status after last patient discharged

On Thursday, a Congolese national walked out of the isolation ward at Mulago national referral hospital in Kampala, and Uganda's clock began to tick. The discharge marked the end of active treatment for the country's last confirmed Ebola patient—and the beginning of a 42-day waiting period that will determine whether Uganda can claim victory over an outbreak that arrived quietly and was contained with remarkable efficiency.

The numbers tell part of the story. Twenty people infected. Two dead. A fatality rate below 10 percent—among the lowest ever recorded in an Ebola outbreak, where previous epidemics have routinely killed three in ten patients. This was not luck. Uganda had invested years in preparedness before the first case appeared: treatment facilities built, emergency medical teams trained, supplies stockpiled. When the virus arrived in May, the machinery was already in place.

But the outbreak's end in Uganda does not mean the crisis is over. Across the border in the Democratic Republic of the Congo, the same Bundibugyo strain continues its spread. By mid-July, confirmed cases had climbed to 2,073, with 796 deaths. The virus shows no respect for borders. Uganda's health minister, Dr. Chris Baryomunsi, acknowledged this reality plainly: the country remains on high alert, watching the DRC's deteriorating situation while celebrating its own containment.

The economic cost of Uganda's outbreak extends far beyond the hospital wards. Fifteen countries have imposed either partial or full travel restrictions on Uganda since the outbreak began. The United States placed the country on a level-four advisory—the same category reserved for North Korea, Somalia, and Afghanistan. Tourism has suffered. Trade has stalled. Business has contracted. Uganda's government is now engaged in quiet diplomacy, asking these nations to reconsider restrictions on a country that has effectively stopped the virus in its tracks.

The scientific response has been equally swift. Oxford University's vaccine research group launched the world's first Phase I clinical trial of a vaccine candidate targeting the Bundibugyo strain this week, with the first patient already enrolled. Uganda participated in trials of experimental therapies during the outbreak and has committed to joining vaccine studies as they develop. The country is not waiting passively for the 42 days to pass.

Cross-border cooperation has become urgent. Uganda's president and the DRC's president have signed a bilateral memorandum of understanding focused on containing the outbreak before it spreads further. Uganda has already deployed 50 health workers to the DRC, along with four mobile laboratories positioned at different locations. More personnel will follow if the situation deteriorates. The outbreak in Uganda may be ending, but the regional emergency is far from over.

Dr. Kasonde Mwinga, the WHO's representative in Uganda, framed the country's success as a vindication of sustained investment in preparedness. "The case fatality rate of less than 10% is among the lowest recorded in Ebola outbreaks because the lowest has always been 30%. That is not by luck," she said. It is a lesson that extends beyond Uganda's borders, a reminder that the difference between catastrophe and containment often comes down to decisions made long before the first patient arrives.